Skip to main content

MARSHALL WACE, LLP

Position in NVCT — Nuvectis Pharma, Inc.

CIK 1318757 LONDON, X0

Position in NVCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$225,892
+$161,521 QoQ
Shares Held
29,223
+173.3% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. NVCT ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVCT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $225,892 29,223
2025-09-30 $64,371 10,693
2025-06-30 $475,189 63,613
2025-03-31 $379,798 38,874
2024-12-31 $673,928 124,571
2024-09-30 $269,299 42,814
2024-06-30 $214,384 33,868
2024-03-31 $410,557 50,068
2023-12-31 $206,940 24,813
2023-09-30 $465,135 36,085
2023-06-30 $667,146 41,775